Nizatide Tablets (Nizatidine)

Adult dose

Adults (15 ∼ 79 years): Administer nizatidine 75 mg orally once daily. If symptoms do not improve after 8 hours, administer an additional 75 mg. Do not exceed 150 mg per day.

This medication should not be taken by individuals with certain diseases or conditions. For example, those who are allergic to this drug or similar medications, or who have experienced anemia or a decrease in blood cell counts, should avoid use. Additionally, individuals already taking other gastrointestinal medications or with blood, liver, kidney, immune-related diseases, or those taking specific antibiotics or chemotherapy agents should consult a healthcare professional before using this medication. Children under 15 years old and elderly individuals over 80 years old, as well as pregnant or nursing women, should also refrain from taking this medication. While taking this medication, it is advised to avoid concomitant use with higher doses of aspirin or specific chemotherapy drugs and antibiotics due to potential interactions. Furthermore, consumption of alcoholic beverages should be avoided, and it is essential to discuss with healthcare professionals any history of allergies or currently taken medications before use. If any unusual symptoms occur during medication, such as skin rashes, difficulty breathing, blood abnormalities, indigestion, liver function abnormalities, or mental changes, immediately discontinue use and notify healthcare personnel. This medication may mask symptoms of stomach cancer; therefore, it should only be used after confirming that it is not gastric cancer, and dosage adjustments may be necessary if kidney or liver function is severely impaired. The duration of use should not exceed 2 weeks, and the prescribed dosage and method of use must be strictly followed. To reduce gastrointestinal discomfort, it is advisable not to lie down immediately after meals, limit caffeine, fried foods, and alcohol intake, and avoid eating just before bedtime. Finally, this medication should be kept out of reach of children.

• Rash
• itching
• bronchial asthma
• laryngeal edema
• hypotension
• bronchospasm
• pharyngeal edema
• dyspnea
• anemia
• pancytopenia

Drug interactions

This medication should not be taken with other gastrointestinal drugs, steroids, antibiotics, chemotherapy agents, azole antifungals, high doses (3,900 mg) of aspirin, gefitinib, prulifloxacin, or atazanavir.

Food interactions

Avoid alcohol consumption while taking this medication. Limit intake of caffeine, chocolate, and fried foods.

This medication should be stored in a tightly closed container to protect it from air or moisture. The storage temperature should be maintained between 1°C and 30°C.

Appearance

Pale yellow round film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle